-
Mashup Score: 0Improving Difficult-to-Treat Asthma With Digital Inhaler Adherence Technologies: Are We There Yet? - 6 month(s) ago
Despite remarkable progress in asthma management and targeted therapies, challenges persist in effectively addressing difficult-to-treat asthma patients. Addressing modifiable factors, such as nonadherence, inadequate inhaler technique, and poorly controlled comorbidities such as those that are asthma mimickers, are necessary for adequate asthma control.1 Sanchis et al2 showed that adherence to asthma inhalers falls below that for medications for other chronic conditions and that correct inhaler use technique has remained unacceptably low over the last 40 years, all of which are a call to action in this space.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Top 5 Ways to Avoid Drug Errors - Drugs.com - 6 month(s) ago
Five simple things you can do to avoid common errors when taking your medications.
Source: www.drugs.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Long-Term Cost-Effectiveness of Digital Inhaler Adherence Technologies in Difficult-to-Treat Asthma - 7 month(s) ago
Digital inhalers can monitor inhaler usage, support difficult-to-treat asthma management, and inform step-up treatment decisions yet their economic value is unknown, hampering wide-scale implementation.
Source: www.jaci-inpractice.orgCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
“There is method to this madness” describes routines that affect adherence to medication regimens.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 7Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure - 8 month(s) ago
Baylor University Medical Center, Dallas, TX; Imperial College, London, UK Baylor Scott and White Research Institute, Dallas, TX; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS Boehringer Ingelheim Pharma GmbH and Co KG, Biberach, Germany Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg,
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5A pilot study of adherence to lenalidomide among older patients with multiple myeloma - 9 month(s) ago
Increased use of orally administered agents in multiple myeloma offers added convenience for patients [1]; however, possible nonadherence is a concern. Retrospective studies have demonstrated that average adherence to oral myeloma therapy ranges from 58 to 90% [2–6]. Measuring adherence is challenging, which may explain the varying estimates.
Source: www.geriatriconcology.netCategories: Hematologists1, Latest HeadlinesTweet-
RT @JGeriOnc: A pilot study of adherence to lenalidomide among older patients with multiple myeloma https://t.co/TRNFUDPalW @MelissaLoh21 @…
-
-
Mashup Score: 0Long-term cost-effectiveness of digital inhaler adherence technologies in difficult-to-treat asthma - 10 month(s) ago
Digital inhalers can monitor inhaler usage, support difficult-to-treat asthma management and inform step-up treatment decisions yet their economic val…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1
Pediatric hematopoietic stem cell transplant (HCT) is a potentially lifesaving, highly intensive treatment that has contributed to improved treatment outcomes f
Source: OUP AcademicCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0Medication adherence in people with asthma | JAA - 11 month(s) ago
Investigating asthma patient and healthcare professionals’ perspectives of medication adherence
Source: www.dovepress.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
This editorial refers to ‘Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid-lowering drugs’, by I. Engebretse
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
In Current Issue (FREE)! Improving Difficult-to- #Treat #Asthma With #Digital #Inhaler #Adherence #Technologies: Are We There Yet? https://t.co/UfFapAV63w